183 related articles for article (PubMed ID: 28949038)
1. Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice.
Rose SJ; Harrast P; Donsante C; Fan X; Joers V; Tansey MG; Jinnah HA; Hess EJ
Mov Disord; 2017 Dec; 32(12):1694-1700. PubMed ID: 28949038
[TBL] [Abstract][Full Text] [Related]
2. A new knock-in mouse model of l-DOPA-responsive dystonia.
Rose SJ; Yu XY; Heinzer AK; Harrast P; Fan X; Raike RS; Thompson VB; Pare JF; Weinshenker D; Smith Y; Jinnah HA; Hess EJ
Brain; 2015 Oct; 138(Pt 10):2987-3002. PubMed ID: 26220941
[TBL] [Abstract][Full Text] [Related]
3. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P
J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205
[TBL] [Abstract][Full Text] [Related]
4. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.
Clot F; Grabli D; Cazeneuve C; Roze E; Castelnau P; Chabrol B; Landrieu P; Nguyen K; Ponsot G; Abada M; Doummar D; Damier P; Gil R; Thobois S; Ward AJ; Hutchinson M; Toutain A; Picard F; Camuzat A; Fedirko E; Sân C; Bouteiller D; LeGuern E; Durr A; Vidailhet M; Brice A;
Brain; 2009 Jul; 132(Pt 7):1753-63. PubMed ID: 19491146
[TBL] [Abstract][Full Text] [Related]
5. Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome.
Rauschendorf MA; Jost M; Stock F; Zimmer A; Rösler B; Rijntjes M; Piroth T; Coenen VA; Reinacher PC; Meyer PT; Frings L; Weiller C; Fischer J; Klebe S
Mov Disord; 2017 Mar; 32(3):478-480. PubMed ID: 27869329
[No Abstract] [Full Text] [Related]
6. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.
Mantas I; Yang Y; Mannoury-la-Cour C; Millan MJ; Zhang X; Svenningsson P
Neuropharmacology; 2020 Jan; 162():107829. PubMed ID: 31666199
[TBL] [Abstract][Full Text] [Related]
8. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
Perez XA; Zhang D; Bordia T; Quik M
Mov Disord; 2017 Apr; 32(4):538-548. PubMed ID: 28256010
[TBL] [Abstract][Full Text] [Related]
9. Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.
Korner G; Noain D; Ying M; Hole M; Flydal MI; Scherer T; Allegri G; Rassi A; Fingerhut R; Becu-Villalobos D; Pillai S; Wueest S; Konrad D; Lauber-Biason A; Baumann CR; Bindoff LA; Martinez A; Thöny B
Brain; 2015 Oct; 138(Pt 10):2948-63. PubMed ID: 26276013
[TBL] [Abstract][Full Text] [Related]
10. Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys.
Stephenson DT; Childs MA; Li Q; Carvajal-Gonzalez S; Opsahl A; Tengowski M; Meglasson MD; Merchant K; Emborg ME
Cell Transplant; 2007; 16(3):229-44. PubMed ID: 17503735
[TBL] [Abstract][Full Text] [Related]
11. Response to levodopa treatment in dopa-responsive dystonia.
Nutt JG; Nygaard TG
Arch Neurol; 2001 Jun; 58(6):905-10. PubMed ID: 11405805
[TBL] [Abstract][Full Text] [Related]
12. Clinical spectrum of dopa-responsive dystonia and related disorders.
Lee WW; Jeon BS
Curr Neurol Neurosci Rep; 2014 Jul; 14(7):461. PubMed ID: 24844652
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.
Mencacci NE; Isaias IU; Reich MM; Ganos C; Plagnol V; Polke JM; Bras J; Hersheson J; Stamelou M; Pittman AM; Noyce AJ; Mok KY; Opladen T; Kunstmann E; Hodecker S; Münchau A; Volkmann J; Samnick S; Sidle K; Nanji T; Sweeney MG; Houlden H; Batla A; Zecchinelli AL; Pezzoli G; Marotta G; Lees A; Alegria P; Krack P; Cormier-Dequaire F; Lesage S; Brice A; Heutink P; Gasser T; Lubbe SJ; Morris HR; Taba P; Koks S; Majounie E; Raphael Gibbs J; Singleton A; Hardy J; Klebe S; Bhatia KP; Wood NW;
Brain; 2014 Sep; 137(Pt 9):2480-92. PubMed ID: 24993959
[TBL] [Abstract][Full Text] [Related]
14. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia.
Furukawa Y; Kapatos G; Haycock JW; Worsley J; Wong H; Kish SJ; Nygaard TG
Ann Neurol; 2002 May; 51(5):637-41. PubMed ID: 12112113
[TBL] [Abstract][Full Text] [Related]
15. The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models.
Jeon MY; Lee WY; Kang HY; Chung EJ
Neurol Res; 2007 Apr; 29(3):289-95. PubMed ID: 17509229
[TBL] [Abstract][Full Text] [Related]
16. Striatal Subregion-selective Dysregulated Dopamine Receptor-mediated Intracellular Signaling in a Model of DOPA-responsive Dystonia.
Roman KM; Briscione MA; Donsante Y; Ingram J; Fan X; Bernhard D; Campbell SA; Downs AM; Gutman D; Sardar TA; Bonno SQ; Sutcliffe DJ; Jinnah HA; Hess EJ
Neuroscience; 2023 May; 517():37-49. PubMed ID: 36871883
[TBL] [Abstract][Full Text] [Related]
17. Residual signs of dopa-responsive dystonia with GCH1 mutation following levodopa treatment are uncommon in Korean patients.
Ahn TB; Chung SJ; Koh SB; Park HY; Cho JW; Lee JH; Hong JY; Kwon DY; Shin C; Lee JY; Lee WW; Jeon B
Parkinsonism Relat Disord; 2019 Aug; 65():248-251. PubMed ID: 31213404
[TBL] [Abstract][Full Text] [Related]
18. Rare causes of dystonia parkinsonism.
Schneider SA; Bhatia KP
Curr Neurol Neurosci Rep; 2010 Nov; 10(6):431-9. PubMed ID: 20694531
[TBL] [Abstract][Full Text] [Related]
19. Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease and Dopa-Responsive Dystonia.
Kawahata I; Fukunaga K
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471089
[TBL] [Abstract][Full Text] [Related]
20. SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response.
Faber I; Martinez ARM; Martins CR; Maia ML; Souza JP; Lourenço CM; Marques W; Montecchiani C; Orlacchio A; Pedroso JL; Barsottini OGP; Ramos CD; Lopes-Cendes Í; Friedman JH; Amorim BJ; França MC
Mov Disord; 2018 Oct; 33(10):1650-1656. PubMed ID: 30306626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
